中医临床研究
中醫臨床研究
중의림상연구
CLINICAL JOURNAL OF CHINESE MEDICINE
2014年
13期
15-16
,共2页
胰岛素抵抗%2型糖尿病%中西医结合
胰島素牴抗%2型糖尿病%中西醫結閤
이도소저항%2형당뇨병%중서의결합
Insulin resistance%Diabetes 2%The integrative medicine
目的:通过观察口服二甲双胍缓释片,合并中药桃仁承气汤加味治疗2型糖尿病胰岛素抵抗证属痰瘀互结证的临床效果,探讨中药的作用机制。方法:80例患者随机分为治疗组和对照组,40例治疗组给予桃仁承气汤加味合并口服二甲双胍缓释片1.0g,2次/日,40例对照组口服二甲双胍缓释片1.0g,2次/d,三个月后观察临床症状,胰岛素抵抗改善情况,判定疗效。结果:治疗组40例,显效15例(37.5%),有效20例(50.0%),无效5例(12.5%),总有效率87.5%。对照组40例,显效11例(27.5%),有效18例(45.0%),无效11例(27.5%),总有效率72.5%。结论:中西医结合论证2型糖尿病证属痰瘀互结证的胰岛素抵抗,疗效显著。
目的:通過觀察口服二甲雙胍緩釋片,閤併中藥桃仁承氣湯加味治療2型糖尿病胰島素牴抗證屬痰瘀互結證的臨床效果,探討中藥的作用機製。方法:80例患者隨機分為治療組和對照組,40例治療組給予桃仁承氣湯加味閤併口服二甲雙胍緩釋片1.0g,2次/日,40例對照組口服二甲雙胍緩釋片1.0g,2次/d,三箇月後觀察臨床癥狀,胰島素牴抗改善情況,判定療效。結果:治療組40例,顯效15例(37.5%),有效20例(50.0%),無效5例(12.5%),總有效率87.5%。對照組40例,顯效11例(27.5%),有效18例(45.0%),無效11例(27.5%),總有效率72.5%。結論:中西醫結閤論證2型糖尿病證屬痰瘀互結證的胰島素牴抗,療效顯著。
목적:통과관찰구복이갑쌍고완석편,합병중약도인승기탕가미치료2형당뇨병이도소저항증속담어호결증적림상효과,탐토중약적작용궤제。방법:80례환자수궤분위치료조화대조조,40례치료조급여도인승기탕가미합병구복이갑쌍고완석편1.0g,2차/일,40례대조조구복이갑쌍고완석편1.0g,2차/d,삼개월후관찰림상증상,이도소저항개선정황,판정료효。결과:치료조40례,현효15례(37.5%),유효20례(50.0%),무효5례(12.5%),총유효솔87.5%。대조조40례,현효11례(27.5%),유효18례(45.0%),무효11례(27.5%),총유효솔72.5%。결론:중서의결합론증2형당뇨병증속담어호결증적이도소저항,료효현저。
Objective: To investigate the oral metformin tablets combined with Taoren Chengqi decoction for insulin resistance in diabetes 2, discuss the mechanism of TCM. Methods: 80 patients were randomly divided into treatment group and control group, 40 cases in the treatment group were given Taoren Chengqi decoction combined with oral metformin tablets 1.0g, 2 times a day, 40 cases in the control group were treated with metformin tablets 1.0g, 2 times a day. Three months later, clinical symptoms and insulin resistance to determine efficacy were observed to determine efficacy. Results: In the treatment group, 40 cases were cured, 15 cases (37.5%) markedly effective, 20 cases (50.0%) effective, 5 cases (12.5%) invalid, the total efficacy was 87.5%. In the control group, 40 cases markedly effective in 11 cases (27.5%), effective in 18 cases (45.0%), invalid in 11 cases (27.5%), the total efficiency was 72.5%. Conclusion: The integrative medicine for insulin resistance of Tanyu Hujie type has good clinical efficacy.